AI assistant
Solid Biosciences Inc. — Director's Dealing 2025
Oct 21, 2025
33003_dirs_2025-10-21_4ee3a5c3-58c3-403c-802c-53bdac755811.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2025-10-18
Reporting Person: Brooks Gabriel (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-18 | Common Stock | M | 9750 | — | Acquired | 36714 | Direct |
| 2025-10-20 | Common Stock | S | 2895 | $5.96 | Disposed | 33819 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-18 | Restricted Stock Units | $ | M | 9750 | Disposed | Common Stock (9750) | Direct |
Footnotes
F1: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
F2: Includes 4,152 shares of common stock acquired under the Solid Biosciences Inc. Employee Stock Purchase Plan on May 30, 2025.
F3: This sale was made to cover withholding taxes following the vesting of previously granted RSUs pursuant to a durable automatic sale instruction letter adopted by Dr. Brooks on August 15, 2024 effecting the sell-to-cover election. The sale does not represent a discretionary trade by Dr. Brooks.
F4: The RSUs were granted on October 18, 2023 (the "Grant Date") and vest over four years, with 25% of the original number of shares vesting on each anniversary of the Grant Date until the fourth such anniversary.